By activating GLP-1 receptors, retatrutide helps stimulate insulin secretion in a glucose-dependent manner, reduces appetite, and slows gastric emptying contributing to improved blood glucose control and reduced caloric intake
After reconstitution, the peptides will remain stable for up to 30 days
Obesity is a major risk factor for type 2 diabetes, cardiovascular diseases, and other comorbidities, creating a pressing need for therapeutic solutions that manage multiple conditions simultaneously
In the SELECT trial that included over 17,000 patients with obesity and established CV disease, but without diabetes, weekly s.c
Considering getting on a GLP1 like Ozempic for weight loss or a range of other benefits
Like most medications, GLP 1s only work while you are taking them